[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Gustafsson et al., 2000 - Google Patents

Biliary lipid composition in patients with cholesterol and pigment gallstones and gallstone‐free subjects: deoxycholic acid does not contribute to formation of …

Gustafsson et al., 2000

Document ID
10517151991951552388
Author
Gustafsson U
Sahlin S
Einarsson C
Publication year
Publication venue
European journal of clinical investigation

External Links

Snippet

Four main disturbances have been attributed to cholesterol gallstone disease: hypersecretion of cholesterol from the liver with cholesterol supersaturation in bile; disturbed motility with defective absorption and secretion by the gallbladder; increased crystallisation …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/573—Immunoassay; Biospecific binding assay for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material

Similar Documents

Publication Publication Date Title
Gustafsson et al. Biliary lipid composition in patients with cholesterol and pigment gallstones and gallstone‐free subjects: deoxycholic acid does not contribute to formation of cholesterol gallstones
Servais et al. Cystinuria: clinical practice recommendation
Corrales et al. Classification of stones according to Michel Daudon: a narrative review
Ahlberg et al. Hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and biliary lipid composition in man: relation to cholesterol gallstone disease and effects of cholic acid and chenodeoxycholic acid treatment
Venneman et al. Small gallstones, preserved gallbladder motility, and fast crystallization are associated with pancreatitis
Hofmann et al. Pretreatment Biliary Lipid Composition in White Patients with Radiol0ucent Gallstones in the National Cooperative Gallstone Study
Ko et al. Biliary sludge is formed by modification of hepatic bile by the gallbladder mucosa
CN105296620B (en) The macro genome signature of enteron aisle is as diabetes B acarbose therapeutic efficacy screening mark
US4992365A (en) Method of detecting bacteria in urine
Lapidus et al. Bile composition in patients with ileal resection due to Crohn's disease
Monzón et al. Mild enteropathy as a cause of iron-deficiency anaemia of previously unknown origin
Gustafsson et al. The effect of vitamin C in high doses on plasma and biliary lipid composition in patients with cholesterol gallstones: prolongation of the nucleation time
Whalley et al. Lithogenic risk factors in normal black volunteers, and black and white recurrent stone formers
Al-Tarawneh et al. Bacterial quality of urinary tract in patients with alkaptonuria
Ladjouze-Rezig et al. Ochronotic rheumatism in Algeria: clinical, radiological, biological and molecular studies—a case study of 14 patients in 11 families
Thamer Pathogenesis, diagnosis and treatment of gallstone disease: a brief review
Åkerlund et al. Effects of colectomy on bile composition, cholesterol saturation and cholesterol crystal formation in humans
Sahlin et al. Hepatic esterification rate of cholesterol and biliary lipids in human obesity.
Chen et al. Human biliary β‐glucuronidase activity before and after relief of bile duct obstruction: Is it the major role in the formation of pigment gallstones?
Thamera Pathogenesis, Diagnosis and Treatment of Gallstone
Jüngst et al. Deoxycholic acid is not related to lithogenic factors in gallbladder bile
RU2222014C1 (en) Method for predicting development of postoperative complications
Al-Toma et al. Henoch–Schönlein purpura presenting as terminal ileitis and complicated by thrombotic microangiopathy
Hudson et al. Mechanisms of gelofusine protection in an in vitro model of polymyxin B-associated renal injury
Basiri et al. Determination of the kidney stone composition using infrared spectroscopy in Iran at a national referral center during 2019–2023